LungLife AI Inc (LLAI) USD0.0001 (DI)
- Add to watchlist
- Create an alert
- This stock can be held in a
n/a
n/a
71.00p
£2.76 million
9.00p
n/a
8.25p
n/a
0.00p (0.00%) Previous:
0.00p
n/a
n/a
20,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 0.05 | 0.02 |
Profit before tax ($m) | (5.41) | (7.60) |
Adjusted EPS (¢): | (21.20) | (29.80) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
LungLife AI upbeat on progress with LungLB test
19 November 2024 12:43
-
LungLife test secures Medicare coverage determination
16 August 2024 10:10
-
Operational update
19 November 2024 07:00
-
Block listing Interim Review
15 November 2024 07:00
-
Directorate Change
25 October 2024 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.